SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018819
Filing Date
2019-05-13
Accepted
2019-05-13 16:03:06
Documents
66
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fixx-10q_20190331.htm 10-Q 2189265
2 EX-31.1 fixx-ex311_6.htm EX-31.1 16540
3 EX-31.2 fixx-ex312_7.htm EX-31.2 18426
4 EX-32.1 fixx-ex321_8.htm EX-32.1 9672
5 EX-32.2 fixx-ex322_9.htm EX-32.2 9926
  Complete submission text file 0001564590-19-018819.txt   8055965

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fixx-20190331.xml EX-101.INS 1998081
7 XBRL TAXONOMY EXTENSION SCHEMA fixx-20190331.xsd EX-101.SCH 52080
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fixx-20190331_cal.xml EX-101.CAL 43210
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fixx-20190331_def.xml EX-101.DEF 162281
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fixx-20190331_lab.xml EX-101.LAB 381908
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fixx-20190331_pre.xml EX-101.PRE 298278
Mailing Address 45 WIGGINS AVE. BEDFORD MA 01730
Business Address 45 WIGGINS AVE. BEDFORD MA 01730 857-305-1825
Homology Medicines, Inc. (Filer) CIK: 0001661998 (see all company filings)

IRS No.: 473468154 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38433 | Film No.: 19818353
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences